‘Moderate-risk’ ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelvi-abdominal irradiation
P. J. HOSKINS, K. D. SWENERTON, M. MANJI, F. WONG, S. E. O'REILLY, E. J. McMURTRIE, N. LE, B. ACKER, J. LE RICHER
International Journal of Gynecologic Cancer Jul 1994, 4 (4) 272-278; DOI: 10.1046/j.1525-1438.1994.04040272.x
